Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Joanne Lundy"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Low skeletal muscle index (SMI) and low skeletal muscle radiodensity (SMD) are associated with reduced survival time in pancreatic ductal adenocarcinoma (PDAC). The negative prognostic impact of low SMI and low SMD is often reported as indep
Externí odkaz:
https://doaj.org/article/5e5c13d983c648ddb8486f3c666e80e5
Autor:
Joanne Lundy, Marion Harris, John Zalcberg, Allan Zimet, David Goldstein, Val Gebski, Adina Borsaru, Christopher Desmond, Michael Swan, Brendan J. Jenkins, Daniel Croagh
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death and lacks effective treatment options. Diagnostic endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) biopsies represent an appealing source of material fo
Externí odkaz:
https://doaj.org/article/ac6b0e5a24c74eb78ba029637dd2e93f
Autor:
Henry Shen, Joanne Lundy, Andrew H. Strickland, Marion Harris, Michael Swan, Christopher Desmond, Brendan J. Jenkins, Daniel Croagh
Publikováno v:
Cells, Vol 11, Iss 19, p 3175 (2022)
Background: KRAS G12D mutation subtype is present in over 40% of pancreatic ductal adenocarcinoma (PDAC), one of the leading global causes of cancer death. This retrospective cohort study aims to investigate whether detection of the KRAS G12D mutatio
Externí odkaz:
https://doaj.org/article/8d82d5b6651f4c8aa3d54c75052b979e
Autor:
Loryn Holokai, Jayati Chakrabarti, Joanne Lundy, Daniel Croagh, Pritha Adhikary, Scott S. Richards, Chantal Woodson, Nina Steele, Robert Kuester, Aaron Scott, Mohammad Khreiss, Timothy Frankel, Juanita Merchant, Brendan J. Jenkins, Jiang Wang, Rachna T. Shroff, Syed A. Ahmad, Yana Zavros
Publikováno v:
Cancers, Vol 12, Iss 12, p 3816 (2020)
Purpose: Pancreatic ductal adenocarcinoma (PDAC) has the lowest five-year survival rate of all cancers in the United States. Programmed death 1 receptor (PD-1)-programmed death ligand 1 (PD-L1) immune checkpoint inhibition has been unsuccessful in cl
Externí odkaz:
https://doaj.org/article/bd17b6c52d204d0fb0a382175e98bdc8
Autor:
Daniel Croagh, Brendan J. Jenkins, Samar Masoumi-Moghoddam, William Berry, Hugh Gao, Joanne Lundy
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis, and current diagnostic tests have suboptimal sensitivity. Incorporating standard cytology with targeted transcriptomic and mutation analysis may improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::174a2d88600deeaf7cc48f9322ebcdaf
https://doi.org/10.1158/1078-0432.c.6530708
https://doi.org/10.1158/1078-0432.c.6530708
Autor:
Daniel Croagh, Brendan J. Jenkins, Samar Masoumi-Moghoddam, William Berry, Hugh Gao, Joanne Lundy
Supplementary tables and figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dffd09b74d921cf54cdf2dc4635eb64
https://doi.org/10.1158/1078-0432.22481507
https://doi.org/10.1158/1078-0432.22481507
Autor:
Gonzalo Tapia-Rico, Joanne Lundy, Gary Richardson, Niky Zhao, Karen Ebsworth, Huibin Yue, Shichiang Miao, Emil deGoma, Rita Jain, Thomas Schall, Kathleen Sullivan, Penglie Zhang, Paul de Souza
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Poornima Varma, Rhys Vaughan, Joanne Lundy, Belinda Lee, Brendan J. Jenkins, Sophia Frentzas, Manoop S. Bhutani, Michael P. Swan, Melissa C. Southey, Vivek Rathi, Hugh Gao, Peter Tagkalidis, Bronte A. Holt, John Zalcberg, Christopher Desmond, Eva Segelov, Marion Harris, Daniel Croagh, Andrew H. Strickland, Charles H.C. Pilgrim, Samar Masoumi-Moghaddam
Publikováno v:
Endoscopic Ultrasound
Background and Objectives: Patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (A-PDAC) are not candidates for surgical resection and are often offered palliative chemotherapy. The ready availability of a safe and effective
Autor:
William R. Berry, Samar Masoumi-Moghoddam, Daniel Croagh, Brendan J. Jenkins, Hugh Gao, Joanne Lundy
Publikováno v:
Clinical Cancer Research. 27:5900-5911
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis, and current diagnostic tests have suboptimal sensitivity. Incorporating standard cytology with targeted transcriptomic and mutation analysis may impro
Autor:
Sean Porazinski, Joanne Lundy, Daniel Croagh, Liang Yu, Hugh Gao, Virginie Deswaerte, Louise McLeod, Paul J. Hertzog, Linden J. Gearing, Alison C. West, Brendan J. Jenkins, Marina Pajic
Publikováno v:
Oncogene. 40:6007-6022
Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis, and is plagued by a paucity of targeted treatment options and tumour resistance to chemotherapeutics. The causal link between chronic inflammation and PDAC suggests that molecul